Novartis' spending on research and development by segment 2017-2023

Novartis AG's spending on research and development by segment from 2017 to 2023

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2024

Region

Worldwide

Survey time period

2017 to 2023

Supplementary notes

All figures are rounded.
* During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's R&D expenses are not included from this year onwards.
** Due to the spin-off of Sandoz during 2023, there was no distribution of R&D spending by segment. The Innovative Medicines segment is now renamed to "Promoted brands".

Open this statistic in...
Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

9

Further related statistics

9
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.